Internal Medicine, Infectious Disease · Mentor, OH
NPI
1013182013
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8587 East Avenue
Mentor, OH, 44060
Phone (440) 867-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$243K
3,752 services
Medicare patients, 2024
854
Average age 76
Drug cost, 2024
$769K
1,649 prescriptions
Company payments, 2025
$633
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olusegun A Ogunlesi was code 99232 (hospital e&m - subsequent), 1,893 times for 540 patients. In total Olusegun A Ogunlesi billed 3,752 services in 29 codes, and Medicare paid $243K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,893 | 540 | $59.08 | $112K |
| 99222 Hospital E&M - Initial | Facility | 531 | 466 | $97.04 | $52K |
| 11042 Debridement | Facility | 253 | 65 | $43.62 | $11K |
| 11045 Debridement | Facility | 152 | 14 | $18.78 | $2,855 |
| 99214 Office E&M - Established | Office | 131 | 111 | $94.63 | $12K |
| 99213 Office E&M - Established | Facility | 128 | 56 | $48.45 | $6,202 |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 56 | $89.19 | $10K |
| 99308 SNF E&M | Facility | 104 | 43 | $48.71 | $5,066 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 87 | 66 | $12.55 | $1,092 |
| 99223 Hospital E&M - Initial | Facility | 60 | 56 | $130.28 | $7,817 |
| 99203 Office E&M - New | Facility | 39 | 39 | $59.83 | $2,333 |
| 99213 Office E&M - Established | Office | 32 | 32 | $59.12 | $1,892 |
| 99305 SNF E&M | Facility | 30 | 29 | $88.81 | $2,664 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 22 | 14 | $12.55 | $276 |
| 99204 Office E&M - New | Office | 22 | 22 | $126.76 | $2,789 |
By year: 2022 $292K for 4,325 services; 2023 $254K for 3,883 services; 2024 $243K for 3,752 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olusegun A Ogunlesi prescribed most often to Medicare patients was Vancomycin Hcl, with 183 prescriptions and refills. In total Olusegun A Ogunlesi wrote 1,649 Medicare prescriptions that cost $769K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 183 | 219 | 48 | $24K |
| Cephalexin Generic | 146 | 304 | 63 | $4,563 |
| Cefepime Hcl Generic | 138 | 138 | 27 | $32K |
| Meropenem Generic | 87 | 87 | 24 | $17K |
| Ertapenem Ertapenem Sodium | 83 | 83 | 24 | $34K |
| Daptomycin Generic | 77 | 77 | 19 | $85K |
| Doxycycline Monohydrate Generic | 70 | 149 | 33 | $4,665 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 68 | 68 | 23 | $14K |
| Ceftriaxone Ceftriaxone Sodium | 65 | 65 | 19 | $9,703 |
| Sodium Chloride 0.9 % Sodium Chloride | 60 | 60 | 14 | $1,181 |
| Doxycycline Hyclate Generic | 49 | 109 | 27 | $2,338 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 41 | 41 | Under 11 | $175K |
| Cefuroxime Cefuroxime Axetil | 41 | 55 | 16 | $1,337 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 37 | 66 | 14 | $847 |
| Tivicay Dolutegravir Sodium | 35 | 43 | Under 11 | $96K |
Brand drugs: 291 claims; generic drugs: 1,358 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olusegun A Ogunlesi $633 ($633 in general payments such as food, travel and fees) from 11 companies. The largest payer was Merck Sharp & Dohme LLC with $153.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 7 | $153 |
| Kerecis Limited | 1 | $132 |
| ViiV Healthcare Company GSK | 3 | $77.81 |
| Abbvie Inc. ABBV | 3 | $71.26 |
| Smith+Nephew, Inc. SNN | 2 | $42.57 |
| Aimmune Therapeutics, Inc. | 2 | $31.35 |
| Insmed, Inc. INSM | 2 | $30.34 |
| Shionogi Inc 4507.T | 1 | $29.13 |
| Tactile Systems Technology Inc TCMD | 1 | $22.88 |
| ConvaTec Inc. CTEC.L | 1 | $21.87 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.